Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Exercise/Conversion of 20,000 TVTX shares, $348.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 20,000 | $348.8K |
| May 7, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 4,250 | n/a |
| Apr 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 14,000 | n/a |
| Feb 5, 2026 | Travere Therapeutics, Inc. (TVTX) | Sale | 1,635 | $52.5K |
| Feb 4, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 28,130 | n/a |
| Dec 3, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 20,000 | $324.6K |
| Sep 5, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 454 | $8.3K |
| Aug 28, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 470 | $8.1K |
| May 6, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 4,920 | n/a |
| Apr 14, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 48 | $630.94 |